GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements
Significant international investment defies sector trend PHILADELPHIA, Dec. 23, 2024 /PRNewswire/ — Today, GEMMA Biotherapeutics (“GEMMABio”) – a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson – announced the completion of a $34 million seed funding round to accelerate its…